Arax Advisory Partners’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
29,356
+10,661
+57% +$654K 0.01% 985
2026
Q1
$1.22M Buy
18,695
+18,491
+9,064% +$1.35M 0.03% 381
2025
Q4
$16.4K Sell
204
-4,657
-96% -$374K ﹤0.01% 2217
2025
Q3
$399K Buy
4,861
+4,602
+1,777% +$399K 0.01% 991
2025
Q2
$23.6K Buy
259
+44
+20% +$3.93K ﹤0.01% 1582
2025
Q1
$19.7K Buy
215
+170
+378% +$14.8K ﹤0.01% 1316
2024
Q4
$3.83K Hold
45
﹤0.01% 1830
2024
Q3
$3.94K Buy
+45
New +$3.79K ﹤0.01% 1814
2022
Q4
Sell
-18
Closed -$1K 1290
2022
Q3
$1K Hold
18
﹤0.01% 1056
2022
Q2
$1K Hold
18
﹤0.01% 1029
2022
Q1
$1K Buy
+18
New +$1.41K ﹤0.01% 1020

Other funds holding DOX

Arax Advisory Partners's DOX Position: Q2 2026 in Review

Arax Advisory Partners increased its Amdocs (DOX) stake by 57% in Q2 2026, buying an estimated $654K and bringing the position to 29,356 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #985.

Arax Advisory Partners first reported a position in DOX in Q1 2022 and has held it in 11 quarters since. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Arax Advisory Partners held 29,356 shares of Amdocs worth $1.48M as of Q2 2026.
  • Arax Advisory Partners bought 10,661 Amdocs shares in Q2 2026, an estimated $654K.
  • Amdocs made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #985 holding.
  • Arax Advisory Partners first reported a position in Amdocs in Q1 2022 and has held it in 11 quarters since.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.